BIOCON LIMITED. (BIOCON) financials

BIOCON LIMITED. (BIOCON) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)

Market Cap: ₹56,909Cr.
Current Price: ₹349
Stock P/E: 189
ROE: 0.91%
ROCE: 1.62%
Book Value: ₹167
Dividend Yield: 0.14%
52W High / Low: ₹447/338

In Jun 2026, BIOCON LIMITED. (BIOCON) reported sales ₹624 Cr and net profit ₹52 Cr.

Annual TTM: sales ₹2,434 Cr, net profit ₹98 Cr.

Shareholding: Promoters 44.68% (Jun 2026), FIIs 8.14% (Jun 2026), DIIs 23.33% (Jun 2026), Government 0.05% (Jun 2026), Public 23.75% (Jun 2026).

BIOCON quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	525	563	644	537	583	621	605	624
Expenses	488	532	582	516	530	548	525	564
Operating Profit	38	31	62	21	53	73	79	61
OPM %	7%	6%	10%	3.8%	9%	12%	13%	10%
Other Income	74	672	63	61	134	-122	31	65
Interest	60	65	57	56	67	2	17	17
Depreciation	30	34	33	33	34	34	36	38
Profit before tax	21	604	35	-8	86	-84	57	70
Tax %	85%	3%	39%	9%	17%	-10%	11%	25%
Net Profit	3	584	21	-8	71	-76	51	52
EPS in Rs	0.03	4.86	0.18	-0.06	0.53	-0.57	0.31	0.32
Raw PDF	—	—	—	—	—	—	—	—

BIOCON profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,988	2,028	1,738	1,993	2,127	2,243	2,346	2,434
Expenses	1,702	1,716	1,677	1,969	1,864	2,066	2,120	2,168
Operating Profit	286	312	61	24	264	177	226	266
OPM %	14%	15%	3.5%	1.2%	12%	8%	10%	11%
Other Income	366	150	187	3,134	206	848	105	108
Interest	1	0	0	70	199	237	142	104
Depreciation	98	104	108	117	121	128	137	142
Profit before tax	553	359	140	2,971	150	661	51	128
Tax %	20%	22%	38%	4%	21%	8%	27%	—
Net Profit	441	280	86	2,848	119	609	37	98
EPS in Rs	3.67	2.34	0.72	23.72	0.99	5.07	0.23	0.59
Dividend Payout %	0%	0%	70%	6%	50%	10%	218%	—

BIOCON balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	300	600	600	600	600	600	600	810
Reserves	6,815	6,937	7,307	7,493	10,316	10,312	10,924	26,269
Borrowings	71	4	2	77	1,301	2,043	2,876	1,153
Other Liabilities	1,054	770	665	699	813	813	1,221	1,038
Total Liabilities	8,240	8,311	8,574	8,869	13,030	13,768	15,621	29,271
Fixed Assets	1,101	793	798	870	961	958	1,114	1,381
CWIP	254	152	179	285	344	560	701	541
Investments	4,093	4,953	5,413	5,280	9,271	9,318	11,383	24,978
Other Assets	2,792	2,413	2,184	2,434	2,454	2,932	2,424	2,371
Total Assets	8,240	8,311	8,574	8,869	13,030	13,768	15,621	29,271

BIOCON cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	110	387	478	48	219	-123	624	-180
Cash from Investing Activity	315	-189	-628	-302	-1,173	-295	-992	-6,580
Cash from Financing Activity	-208	-129	28	112	1,039	344	495	6,602
Net Cash Flow	217	69	-122	-142	86	-74	127	-158
Free Cash Flow	-148	195	420	-197	-45	-429	302	-469
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	117%	167%	173%	124%	1,103%	-36%	376%	-70%

BIOCON shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	60.64%	60.64%	60.64%	54.45%	54.45%	54.45%	44.91%	44.68%
FIIs	5.93%	5.66%	5.67%	6.04%	6.61%	7.39%	7.52%	8.14%
DIIs	14.44%	15.36%	15.73%	22.83%	22.06%	21.67%	24.01%	23.33%
Government	0.00%	0.00%	0.00%	0.00%	0.03%	0.03%	0.05%	0.05%
Public	18.74%	18.11%	17.77%	16.51%	16.70%	16.34%	23.40%	23.75%
Others	0.25%	0.22%	0.21%	0.18%	0.14%	0.12%	0.09%	0.05%
No. of Shareholders	4,39,503	4,27,705	4,24,297	4,28,131	4,13,191	3,94,279	3,86,593	3,92,833

BIOCON key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	184	105	106	147	121	180	135	156
Inventory Days	371	236	197	245	208	260	296	299
Days Payable	298	230	170	172	169	175	288	201
Cash Conversion Cycle	257	111	133	220	159	265	143	254
Working Capital Days	214	154	122	181	151	244	30	9
ROCE %	5%	5%	5%	2%	2%	3%	2%	2%

BIOCONUpdated 19 Oct 2026, 5:03

Biocon Limited.

BIOCONUpdated 19 Oct 2026, 5:03

Market Cap

₹56,909Cr.

Current Price

₹349

High / Low

₹447/338

Stock P/E

189

ROE0.91%

ROCE1.62%

Book Value₹167

Face Value₹5.00

Dividend Yield0.14%

About

Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	513	48	441	56	30	50	6	47	0.39
Sep 2023	519	55	452	64	31	46	25	35	0.29
Dec 2023	563	56	492	48	31	33	27	24	0.2
Mar 2024	533	40	480	39	30	22	36	14	0.12
Jun 2024	511	55	466	42	30	1	18	1	0.01
Sep 2024	525	60	488	74	30	21	85	3	0.03
Dec 2024	563	65	532	672	34	604	3	584	4.86
Mar 2025	644	57	582	63	33	35	39	21	0.18
Jun 2025	537	56	516	61	33	-8	9	-8	-0.06
Sep 2025	583	67	530	134	34	86	17	71	0.53
Dec 2025	621	2	548	-122	34	-84	-10	-76	-0.57
Mar 2026	605	17	525	31	36	57	11	51	0.31
Jun 2026	624	17	564	65	38	70	25	52	0.32

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	2242	1	1812	127	128	428	16	361	3.01
Mar 2016	2302	2	1880	279	140	559	34	369	3.07
Mar 2017	2588	4	1996	99	151	536	3	519	4.33
Mar 2018	2419	1	2101	125	136	306	22	238	1.99
Mar 2019	1786	3	1575	422	92	537	8	493	4.11
Mar 2020	1988	1	1702	366	98	553	20	441	3.67
Mar 2021	2028	0	1716	150	104	359	22	280	2.34
Mar 2022	1738	0	1677	187	108	140	38	86	0.72
Mar 2023	1993	70	1969	3134	117	2971	4	2848	23.72
Mar 2024	2127	199	1864	206	121	150	21	119	0.99
Mar 2025	2243	237	2066	848	128	661	8	609	5.07
Mar 2026	2346	142	2120	105	137	51	27	37	0.23
TTM	2434	104	2168	108	142	128	—	98	0.59

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	44.68%
FIIs	8.14%
DIIs	23.33%
Government	0.05%
Public	23.75%
Others	0.05%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public	Others
Sep 2023	60.64%	7.97%	14.08%	0%	16.92%	0.39%
Dec 2023	60.64%	6.55%	14.51%	0%	17.96%	0.33%
Mar 2024	60.64%	5.63%	13.69%	0%	19.74%	0.32%
Jun 2024	60.64%	5.9%	14.29%	0%	18.9%	0.28%
Sep 2024	60.64%	5.93%	14.44%	0%	18.74%	0.25%
Dec 2024	60.64%	5.66%	15.36%	0%	18.11%	0.22%
Mar 2025	60.64%	5.67%	15.73%	0%	17.77%	0.21%
Jun 2025	54.45%	6.04%	22.83%	0%	16.51%	0.18%
Sep 2025	54.45%	6.61%	22.06%	0.03%	16.7%	0.14%
Dec 2025	54.45%	7.39%	21.67%	0.03%	16.34%	0.12%
Mar 2026	44.91%	7.52%	24.01%	0.05%	23.4%	0.09%
Jun 2026	44.68%	8.14%	23.33%	0.05%	23.75%	0.05%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	100	2484	82	667	3333	914	58	165	2196	3333
Mar 2016	100	5897	370	732	7098	894	172	3853	2179	7098
Mar 2017	100	6441	134	794	7469	938	241	3888	2402	7469
Mar 2018	300	6439	133	855	7727	903	318	4199	2307	7727
Mar 2019	300	6815	71	1054	8240	1101	254	4093	2792	8240
Mar 2020	600	6937	4	770	8311	793	152	4953	2413	8311
Mar 2021	600	7307	2	665	8574	798	179	5413	2184	8574
Mar 2022	600	7493	77	699	8869	870	285	5280	2434	8869
Mar 2023	600	10316	1301	813	13030	961	344	9271	2454	13030
Mar 2024	600	10312	2043	813	13768	958	560	9318	2932	13768
Mar 2025	600	10924	2876	1221	15621	1114	701	11383	2424	15621
Mar 2026	810	26269	1153	1038	29271	1381	541	24978	2371	29271

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	125	145	-158	112
Mar 2016	208	-313	73	-32
Mar 2017	186	104	-238	52
Mar 2018	355	-553	-55	-252
Mar 2019	110	315	-208	217
Mar 2020	387	-189	-129	69
Mar 2021	478	-628	28	-122
Mar 2022	48	-302	112	-142
Mar 2023	219	-1173	1039	86
Mar 2024	-123	-295	344	-74
Mar 2025	624	-992	495	127
Mar 2026	-180	-6580	6602	-158

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	90	80	113	112	184	105	106	147	121	180	135	156
Inventory Days	148	187	190	195	371	236	197	245	208	260	296	299
Days Payable	109	146	159	202	298	230	170	172	169	175	288	201
Cash Conversion Cycle	129	121	144	105	257	111	133	220	159	265	143	254
Working Capital Days	76	42	108	87	214	154	122	181	151	244	30	9
ROCE %	17%	10%	8%	4%	5%	5%	5%	2%	2%	3%	2%	2%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of BIOCON LIMITED. (BIOCON)?

The reported market capitalisation for BIOCON LIMITED. (BIOCON) is ₹56,909Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of BIOCON?

The current price shown for BIOCON LIMITED. (BIOCON) on Fincrux is ₹349 with a 52-week high/low of ₹447/338.

What is the P/E ratio of BIOCON LIMITED. (BIOCON)?

The stock P/E for BIOCON LIMITED. (BIOCON) is 189 on Fincrux, with ROE at 0.91% and ROCE at 1.62%.

What were BIOCON latest quarterly results?

For Jun 2026, BIOCON LIMITED. (BIOCON) reported sales ₹624 Cr and net profit ₹52 Cr (figures in ₹ crore unless noted).

What are BIOCON annual sales and net profit?

For TTM, BIOCON LIMITED. (BIOCON) shows sales of ₹2,434 Cr and net profit of ₹98 Cr on the Fincrux profit & loss statement.

Who owns BIOCON LIMITED. (BIOCON)?

Latest shareholding for BIOCON LIMITED. (BIOCON) on Fincrux: Promoters 44.68% (Jun 2026), FIIs 8.14% (Jun 2026), DIIs 23.33% (Jun 2026), Government 0.05% (Jun 2026), Public 23.75% (Jun 2026).

Where can I find BIOCON LIMITED. (BIOCON) financials?

BIOCON LIMITED. (BIOCON) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show BIOCON balance sheet and cash flow?

Yes. The BIOCON LIMITED. (BIOCON) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 5:03